SCHEMBL6376248

SCHEMBL6376248

CN(C)c1ccc(NC(=O)C(Cc2ccccc2)NC(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.62
FPR2 P25090 9/20 0.53
CNR1 P21554 2/20 0.53
MMP1 P03956 2/20 0.52
NOX1 Q9Y5S8 2/20 0.50
UTS2R Q9UKP6 1/20 0.49
S1PR1 P21453 1/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
RAB9A P51151 1/20 0.48
NFKB2 Q00653 1/20 0.48
KMT2A Q03164 1/20 0.48
RELA Q04206 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6376414 1.00 F7 (0.62) F7FPR2CNR1MMP1NOX1
SCHEMBL6376244 1.00 F7 (0.62) F7FPR2CNR1MMP1NOX1
SCHEMBL6376756 0.90 NPY1R (0.56) F7FPR2CNR1MMP1NOX1
SCHEMBL6376376 0.90 NPY1R (0.56) F7FPR2CNR1MMP1NOX1
SCHEMBL6376369 0.90 NPY1R (0.56) F7FPR2CNR1MMP1NOX1
SCHEMBL6410493 0.86 MMP1 (0.57) F7MMP1NOX1MEN1NPC1
SCHEMBL29687042 0.83 F7 (0.66) F7FPR2NOX1NPC1MAPT
SCHEMBL18983568 0.81 SMN1; SMN2 (0.56) FPR2MMP1S1PR1MEN1MAPT
SCHEMBL3450270 0.81 FPR2 (0.76) FPR2CNR1MEN1NPC1RAB9A
SCHEMBL6379132 0.81 FPR2 (0.76) FPR2CNR1MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050137230-A1 Carboxamide derivatives DORSCH DIETER (DE) 2005-06-23 US claimed
US-20050137230-A1 Carboxamide derivatives DORSCH DIETER (DE) 2005-06-23 US disclosed
US-20040038858-A1 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours MERCK PATENT GMBH (DE) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137230-A1 Carboxamide derivatives F11, F12, F2 F7 60/4885FPR2 766/4885CNR1 6/4885
US-20040038858-A1 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours CNR2, CNR1, HCAR2 F7 509/4885FPR2 176/4885CNR1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.